Elevation of Lipid Metabolites in Deceased Liver Donors Reflects Graft Suffering.
Wei-Chen LeeTing-Jung WuChih-Hsien ChengYu-Chao WangHao-Chien HungJin-Chiao LeeTsung-Han WuHong-Shiue ChouChen-Fang LeeKun-Ming ChanPublished in: Metabolites (2023)
Liver transplantation can be performed with deceased or living donor allografts. Deceased liver grafts are donated from brain- or circulation-death patients, and they have usually suffered from a certain degree of damage. Post-transplant graft function and patient survival are closely related to liver allograft recovery. How to define the damage of liver grafts is unclear. A total of 47 liver donors, 23 deceased and 24 living, were enrolled in this study. All deceased donors had suffered from severe brain damage, and six of them had experienced cardio-pulmonary-cerebral resuscitation (CPR). The exploration of liver graft metabolomics was conducted by liquid chromatography coupled with mass spectrometry. Compared with living donor grafts, the deceased liver grafts expressed higher levels of various diacylglycerol, lysophosphatidylcholine, lysophosphatidylethanolamine, oleoylcarnitine and linoleylcarnitine; and lower levels of cardiolipin and phosphatidylcholine. The liver grafts from the donors with CPR had higher levels of cardiolipin, phosphatidic acid, phosphatidylcholine, phatidylethanolamine and amiodarone than the donors without CPR. When focusing on amino acids, the deceased livers had higher levels of histidine, taurine and tryptophan than the living donor livers. In conclusion, the deceased donors had suffered from cardio-circulation instability, and their lipid metabolites were increased. The elevation of lipid metabolites can be employed as an indicator of liver graft suffering.
Keyphrases
- kidney transplantation
- mass spectrometry
- cardiac arrest
- liquid chromatography
- ms ms
- end stage renal disease
- cardiopulmonary resuscitation
- fatty acid
- multiple sclerosis
- chronic kidney disease
- high resolution
- pulmonary hypertension
- ejection fraction
- peritoneal dialysis
- amino acid
- cerebral ischemia
- high resolution mass spectrometry